William G. Powderly

28.7k total citations · 6 hit papers
301 papers, 19.4k citations indexed

About

William G. Powderly is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, William G. Powderly has authored 301 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Infectious Diseases, 143 papers in Epidemiology and 68 papers in Emergency Medicine. Recurrent topics in William G. Powderly's work include HIV/AIDS drug development and treatment (86 papers), Antifungal resistance and susceptibility (71 papers) and HIV-related health complications and treatments (67 papers). William G. Powderly is often cited by papers focused on HIV/AIDS drug development and treatment (86 papers), Antifungal resistance and susceptibility (71 papers) and HIV-related health complications and treatments (67 papers). William G. Powderly collaborates with scholars based in United States, Ireland and United Kingdom. William G. Powderly's co-authors include William E. Dismukes, Robert A. Larsen, Richard J. Hamill, Jack D. Sobel, Michael S. Saag, Pablo Tebas, Kevin E. Yarasheski, John R. Perfect, John R. Graybill and Peter G. Pappas and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

William G. Powderly

288 papers receiving 18.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

2010 1.7k citations John R. Perfect, William E. Dismukes et al. Clinical Infectious Diseases profile →
Practice Guidelines for the Management of Cryptococcal Disease

2000 781 citations Robert A. Larsen, John R. Perfect et al. Clinical Infectious Diseases profile →
A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients

2003 666 citations Peter G. Pappas, Richard J. Hamill et al. Clinical Infectious Diseases profile →
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

1997 540 citations Richard J. Hamill, John R. Graybill et al. profile →
Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

2008 500 citations William G. Powderly et al. profile →
Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis

1992 470 citations William G. Powderly, William E. Dismukes et al. profile →

Peers

Countries citing papers authored by William G. Powderly

Since Specialization

Citations

This map shows the geographic impact of William G. Powderly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William G. Powderly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William G. Powderly more than expected).

Fields of papers citing papers by William G. Powderly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William G. Powderly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William G. Powderly. The network helps show where William G. Powderly may publish in the future.

Co-authorship network of co-authors of William G. Powderly

This figure shows the co-authorship network connecting the top 25 collaborators of William G. Powderly. A scholar is included among the top collaborators of William G. Powderly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William G. Powderly. William G. Powderly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiretroviral Therapy and Cardiovascular Risk in People With HIV in the United States—An Updated Analysis 2024 ·Open Forum Infectious Diseases ·Luis Parra-Rodriguez, John M. Sahrmann, Anne M. Butler, Margaret A. Olsen, William G. Powderly, Jane A. O’Halloran	2
2	Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri 2022 ·PLoS Medicine ·Aaloke Mody, Cory Bradley, (unknown), (unknown), Ingrid Eshun‐Wilson, (unknown), (unknown), Khai Hoan Tram, Lindsey M. Filiatreau, (unknown), (unknown), George Turabelidze, Vetta L. Sanders Thompson, William G. Powderly, Elvin Geng	16
3	Long-Term Mortality after Histoplasma Infection in People with HIV 2021 ·Journal of Fungi ·(unknown), (unknown), Adriana M. Rauseo, (unknown), Lindsey Larson, (unknown), Jane A. O’Halloran, Rachel M. Presti, William G. Powderly, Andrej Spec	8
4	Understanding Drivers of Coronavirus Disease 2019 (COVID-19) Racial Disparities: A Population-Level Analysis of COVID-19 Testing Among Black and White Populations 2020 ·Clinical Infectious Diseases ·Aaloke Mody, (unknown), Cory Bradley, (unknown), (unknown), Will Ross, Vetta L. Sanders Thompson, Karen E. Joynt Maddox, Mat Reidhead, Mario Schootman, William G. Powderly, Elvin Geng	33
5	Adopting locally the lessons learned globally: a call to action for academic medical centres in the USA 2020 ·BMJ Global Health ·Corrado Cancedda, Lisa V. Adams, William G. Powderly	0
6	Sex Venue-Based Network Analysis to Identify HIV Prevention Dissemination Targets for Men Who Have Sex with Men 2018 ·LGBT Health ·Rupa Patel, Douglas A. Luke, Enola K. Proctor, William G. Powderly, Philip A. Chan, Kenneth H. Mayer, Lawrence E. Harrison, Amar Dhand	5
7	Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients 2016 ·Journal of Clinical Gastroenterology ·Mohammed Saeed, Margaret A. Olsen, William G. Powderly, Rachel M. Presti	16
8	Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment 2016 ·BMJ Open ·Andrew Hill, Dzintars Gotham, Joseph Fortunak, (unknown), (unknown), Manuel de Mora Martín, Haitham Shoman, Jacob Levi, William G. Powderly, Mark Bower	46
9	Human Immunodeficiency Virus Type 1 in Ireland: Phylogenetic Evidence for Risk Group-Specific Subepidemics 2011 ·AIDS Research and Human Retroviruses ·Cillian De Gascun, Allison Waters, (unknown), Jane A. O’Halloran, (unknown), Suzie Coughlan, Colm Bergin, William G. Powderly, William W. Hall	3
10	Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America breakdown → 2010 ·Clinical Infectious Diseases ·John R. Perfect, William E. Dismukes, Françoise Dromer, David L. Goldman, John R. Graybill, Richard J. Hamill, Thomas S. Harrison, Robert A. Larsen, Olivier Lortholary, (unknown), Peter G. Pappas, William G. Powderly, Nina Singh, Jack D. Sobel, Tania C. Sorrell	1749
11	Insulin resistance is independently associated with VAT and upper trunk SAT in controls and HIV infection 2006 ·Antiviral Therapy ·Carl Grünfeld, David Rimland, Cynthia L. Gibert, William G. Powderly, Steven Sidney, S.M. Haffner, Michael G. Shlipak, S. B. Heymsfield, Rebecca Scherzer	2
12	Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kathleen Squires, Adriano Lazzarin, (unknown), William G. Powderly, Vadim Pokrovskiy, (unknown), Joseph G. Jemsek, Antonio Rivero, Willy Rozenbaum, Shannon Schrader, Michael Sension, Asda Vibhagool, Alexandra Thiry, Michael Giordano	238
13	Clinical Management of HIV Infection 2003 ·William G. Powderly	1
14	Manual of HIV therapeutics 2001 ·Lippincott Williams & Wilkins eBooks ·William G. Powderly	4
15	Molecular Epidemiology of Mucosal Candidiasis in HIV-Positive Women 1997 ·AIDS Research and Human Retroviruses ·(unknown), Elizabeth J. Keath, Victoria J. Fraser, William G. Powderly	10
16	Rifabutin Induced Vitritis in AIDS Patients 1996 ·Ocular Immunology and Inflammation ·Levent Akduman, Lucian V. Del Priore, Henry J. Kaplan, William G. Powderly	2
17	Resistant Candidiasis 1995 ·Aids Patient Care ·William G. Powderly	3
18	Resistant Candidiasis 1994 ·AIDS Research and Human Retroviruses ·William G. Powderly	45
19	Alterations in Spliced and Unspliced HIV-1-Specific RNA Detection in Peripheral Blood Mononuclear Cells of Individuals with Varying CD4-Positive Lymphocyte Counts 1993 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), (unknown), J. Philip Miller, William G. Powderly, Lee Ratner	14
20	Renal glomerulopathies associated with Hodgkin's disease 1985 ·Cancer ·William G. Powderly, Brian M.J. Cantwell, J. J. Fennelly, Padraig Warde, Mary Margaret McCabe, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact